Wellington Management Group
PDSB icon

Wellington Management Group’s PDS Biotechnology PDSB Stock Holding History

Wellington Management Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,393
Closed -$29K – 2286
2018
Q2 		$29K Buy
+1,393
New +$29.1K ﹤0.01% 2216

Other funds holding PDSB

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Wellington Management Group's PDSB Position: Q3 2018 in Review

Wellington Management Group sold out of PDS Biotechnology (PDSB) in Q3 2018, closing a stake of 1,393 shares — an estimated $29K sold.

Wellington Management Group first reported a position in PDSB in Q2 2018 and held it in 1 quarter. The position peaked at $29K in Q2 2018. 37 funds tracked by Wall St. Rank hold PDSB as of Q3 2018.

  • Wellington Management Group reported no remaining PDS Biotechnology position as of Q3 2018 after selling out during the quarter.
  • Wellington Management Group sold 1,393 PDS Biotechnology shares in Q3 2018, an estimated $29K.
  • Wellington Management Group first reported a position in PDS Biotechnology in Q2 2018 and held it in 1 quarter.
  • Wellington Management Group's PDS Biotechnology position peaked at $29K in Q2 2018.
  • 37 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2018.

Based on Wellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.